Owner Janssen Pharmaceutica N.V.

Inventors Wall, Mark J.; Illig, Carl R.; Chen, Jinsheng; Meegalla, Sanath K.

Agent Shelston IP

Pub. Number AU-A-2008312540

PCT Pub. Number WO2009/052237

Priority 60/980,623 17.10.07 US

Filing date 16 October 2008

Wipo publication date 23 April 2009

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 19/02 (2006.01) Drugs for skeletal disorders

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 493/08 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61P 35/00 (2006.01) Antineoplastic agents